Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MiMedx logo — company profile

MiMedx

Founded 2008 United States Marietta, United States 835 employees Grant Total: $266.36M Biotechnology, Health Care +3

General Information

Company Name MiMedx
Founded Year 2008
Location United States Marietta, United States +2
Founders / Decision Makers
Team member Team member Team member
Employees 835
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Grant
Social

Get notified when MiMedx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MiMedx

MiMedx is a pioneering company in the biotechnology and healthcare industries, specializing in placental tissue products. Established in 2008 and headquartered in the United States, the company has been at the forefront of developing solutions for chronic and hard-to-heal wounds, with a commitment to enhancing the quality of life for patients. Its extensive experience spanning over a decade reflects its dedication to providing a leading portfolio of products for wound care, burn, and surgical applications within the healthcare sector. In its most recent funding round on 31 May 2022, MiMedx secured a significant investment of $4.60M from the Medical Technology Enterprise Consortium. This injection of capital underscores the confidence of industry investors in the company's vision. It is evident that the support from such a reputable investor further strengthens MiMedx's position and aids in its relentless pursuit of innovation to deliver healing solutions to a global market. MiMedx's focus on innovation and its ability to attract investments from leading industry players positions the company as a key player in the healthcare sector. With a clear vision to be the leading global provider of healing solutions, MiMedx is well-equipped to continue driving advancements in the field of placental tissue and furthering its impact on patient care and outcomes.

Taxonomy: Advanced wound care, Therapeutic biologics, Human placental tissue allografts, Patent-protected processes, Placental tissue processing, PURION® process methodology, Aseptic processing techniques, Terminal sterilization, Allograft distribution, Biomedical technology, Medical innovations

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 31 May 2022
Post-IPO Debt •••••• 1 •••• •••• 02 Jul 2020
Post-IPO Equity •••••• 1 •••• •••• 02 Jul 2020
Post-IPO Debt •••••• - 12 Jun 2019
Post-IPO Equity •••••• - 18 Dec 2013

View All 7 Funding Rounds

MiMedx Alternatives & Competitors

MiMedx vs
Snoasis Medical, LLC
Snoasis Medical, LLC United States

Developing regenerative solutions for dental surgery, enhancing healing with state-of-the-art allogr...

Grant
8 employees
Health Care, Medical Devices
Compare MiMedx vs Snoasis Medical, LLC
MiMedx vs
BioStem Technologies (OTC: BSEM)
BioStem Technologies (OTC: BSEM) United States

We Manufacture Products That Change Lives

Post Ipo Equity
47 employees
Biotechnology, Pharmaceutical
Compare MiMedx vs BioStem Technologies (OTC: BSEM)
MiMedx vs
Surgical Biologics LLC
Surgical Biologics LLC

Surgical Biologics is the leader in the development and manufacture of placental-based allografts,...

4 employees
Biotechnology, Health Care
Also compare with: MiMedx vs Stability Biologics Stability Biologics

FAQ About MiMedx

MIMEDX is a pioneer and leader in the field of placental tissue. With more than a decade of helping clinicians manage chronic and hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical settings of healthcare. The C...
MiMedx was founded in 2008.
MiMedx is headquartered in Marietta, United States.
MiMedx operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices, Marketing.
MiMedx has approximately 835 employees.
MiMedx has completed 7 funding rounds, raising a total of $266.36M. The latest funding stage is Grant.
Top alternatives and competitors to MiMedx include Snoasis Medical, LLC, BioStem Technologies (OTC: BSEM), Surgical Biologics LLC, CellSave, AlphaCord. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MiMedx and Snoasis Medical, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MiMedx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy